A Phase II Randomized, Sham-Controlled, Double-Blind, Dose-Finding Study to Assess the Efficacy and Safety of Transurethral Photodynamic Therapy With Lemuteporfin in Subjects With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.
Phase of Trial: Phase II
Latest Information Update: 02 Oct 2006
At a glance
- Drugs Lemuteporfin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Acronyms PLUS
- Sponsors Novelion Therapeutics
- 27 Nov 2005 New trial record.